Monte Financial Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.11M | Sell |
50,754
-106
| -0.2% | -$12.2K | 2.17% | 16 |
|
|
2025
Q4 | $5.35M | Sell |
50,860
-519
| -1% | -$48.7K | 2% | 23 |
|
|
2025
Q3 | $4.31M | Buy |
51,379
+2,289
| +5% | +$189K | 1.59% | 33 |
|
|
2025
Q2 | $3.89M | Sell |
49,090
-14,033
| -22% | -$1.12M | 1.51% | 34 |
|
|
2025
Q1 | $4.92M | Buy |
63,123
+8,505
| +16% | +$794K | 2.16% | 23 |
|
|
2024
Q4 | $5.43M | Buy |
54,618
+6,592
| +14% | +$680K | 2.33% | 17 |
|
|
2024
Q3 | $5.45M | Buy |
48,026
+760
| +2% | +$90.3K | 2.26% | 23 |
|
|
2024
Q2 | $5.85M | Sell |
47,266
-87
| -0.2% | -$11.2K | 2.58% | 11 |
|
|
2024
Q1 | $6.25M | Sell |
47,353
-48
| -0.1% | -$5.92K | 2.74% | 8 |
|
|
2023
Q4 | $5.17M | Buy |
47,401
+4,373
| +10% | +$454K | 2.41% | 16 |
|
|
2023
Q3 | $4.43M | Buy |
43,028
+867
| +2% | +$93.4K | 2.24% | 24 |
|
|
2023
Q2 | $4.86M | Sell |
42,161
-2,905
| -6% | -$330K | 2.37% | 22 |
|
|
2023
Q1 | $4.79M | Sell |
45,066
-7,880
| -15% | -$851K | 2.53% | 16 |
|
|
2022
Q4 | $5.87M | Sell |
52,946
-4,272
| -7% | -$437K | 3.02% | 6 |
|
|
2022
Q3 | $4.93M | Sell |
57,218
-9,670
| -14% | -$863K | 3.02% | 7 |
|
|
2022
Q2 | $6.1M | Sell |
66,888
-86
| -0.1% | -$7.62K | 3.56% | 4 |
|
|
2022
Q1 | $5.5M | Buy |
66,974
+2,067
| +3% | +$163K | 2.93% | 11 |
|
|
2021
Q4 | $4.97M | Sell |
64,907
-1,911
| -3% | -$152K | 2.62% | 16 |
|
|
2021
Q3 | $5.02M | Buy |
66,818
+8,056
| +14% | +$613K | 2.88% | 12 |
|
|
2021
Q2 | $4.57M | Sell |
58,762
-1,483
| -2% | -$110K | 2.61% | 20 |
|
|
2021
Q1 | $4.43M | Buy |
60,245
+10,173
| +20% | +$750K | 2.72% | 17 |
|
|
2020
Q4 | $3.91M | Sell |
50,072
-153
| -0.3% | -$11.7K | 2.66% | 15 |
|
|
2020
Q3 | $3.98M | Sell |
50,225
-2,342
| -4% | -$183K | 3% | 7 |
|
|
2020
Q2 | $3.88M | Buy |
52,567
+6,282
| +14% | +$473K | 3.07% | 9 |
|
|
2020
Q1 | $3.4M | Buy |
46,285
+262
| +0.6% | +$20.6K | 3.29% | 5 |
|
|
2019
Q4 | $3.99M | Buy |
46,023
+2,710
| +6% | +$223K | 2.94% | 8 |
|
|
2019
Q3 | $3.48M | Buy |
43,313
+828
| +2% | +$66.4K | 2.81% | 13 |
|
|
2019
Q2 | $3.4M | Sell |
42,485
-3,250
| -7% | -$249K | 2.88% | 9 |
|
|
2019
Q1 | $3.63M | Sell |
45,735
-2,521
| -5% | -$189K | 3.18% | 7 |
|
|
2018
Q4 | $3.52M | Sell |
48,256
-2,341
| -5% | -$165K | 3.72% | 2 |
|
|
2018
Q3 | $3.42M | Sell |
50,597
-8
| -0% | -$510 | 3.2% | 6 |
|
|
2018
Q2 | $2.93M | Buy |
50,605
+4,401
| +10% | +$248K | 2.98% | 11 |
|
|
2018
Q1 | $2.4M | Buy |
46,204
+39,353
| +574% | +$2.13M | 2.51% | 18 |
|
|
2017
Q4 | $368K | Buy |
+6,851
| New | +$380K | 0.37% | 48 |
|
Other funds holding MRK
VCM
VPM
Monte Financial Group's MRK Position: Q1 2026 in Review
Monte Financial Group reduced its Merck (MRK) stake by 0.21% in Q1 2026, selling an estimated $12.2K and leaving 50,754 shares worth $6.11M. The position accounts for 2.17% of the portfolio, ranked #16.
Monte Financial Group first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. The position peaked at $6.25M in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Monte Financial Group held 50,754 shares of Merck worth $6.11M as of Q1 2026.
- Monte Financial Group sold 106 Merck shares in Q1 2026, an estimated $12.2K.
- Merck made up 2.17% of Monte Financial Group's portfolio in Q1 2026, its #16 holding.
- Monte Financial Group first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
- Monte Financial Group's Merck position peaked at $6.25M in Q1 2024.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Monte Financial Group's 13F filing for Q1 2026, filed 14 May 2026.